Lv51
1380 积分 2021-05-26 加入
The Impact of the Rate of Weight Loss on Body Composition and Metabolism
1小时前
已完结
Association of GLP-1RA discontinuation and risk of depressive and anxiety disorders in people with type 2 diabetes: a cohort study
1个月前
已完结
中国糖尿病合并慢性肾脏病临床管理共识
1个月前
已完结
31st European Congress on Obesity (ECO 2024)
1个月前
已完结
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data
1个月前
已关闭
Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
1个月前
已完结
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
2个月前
已完结
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5
2个月前
已完结
Survodutide Once Weekly for the Treatment of Adults with Obesity
2个月前
已完结
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
2个月前
已完结
皖公网安备34019202002308
